Glomerulonephritis Press Release
| Post date | Title | Picture |
|---|---|---|
| Fri, 10/24/2025 - 06:40 | Notice Concerning Making Renalys Pharma, Inc. a Wholly-Owned Subsidiary |
 |
| Thu, 10/16/2025 - 12:56 | Less can be more: Low-dose steroids could effectively treat severe kidney inflammation |
 |
| Thu, 02/20/2025 - 04:33 | EMA validates indication extension application for Aspaveli for treatment of C3G and primary IC-MPGN |
 |
| Thu, 08/08/2024 - 16:43 | Sobi and Apellis announce positive topline results from phase 3 VALIANT study of pegcetacoplan in C3G and primary IC-MPGN |
|
| Mon, 06/07/2021 - 08:22 | Novartis announces new interim analysis Phase II data for iptacopan in rare kidney disease C3 glomerulopathy (C3G) |
 |
| Fri, 10/23/2020 - 05:26 | Novartis announces European Medicines Agency (EMA) has granted orphan drug designation for iptacopan (LNP023) in IgA nephropathy (IgAN) |
|
| Mon, 04/29/2019 - 11:12 | Study links patrolling monocytes to lupus-related kidney disease |
 |
